2022 Editorial Calendar
Content themes:
- Industry Radar: Tracking the performance of the global bio/pharmaceutical industry and leading market sectors and the macro issues impacting the industry.
- The CDMO/CMO and Suppliers Report: The keys developments CDMOs/CMOs and suppliers and trends shaping bio/pharmaceutical outsourcing and supply.
- Manufacturing and Supply Lines: The latest from the bio/pharmaceutical/ manufacturing value chain, from raw materials to active pharmaceutical ingredients (small molecules and biologics) to drug products to packaging.
- Supplier Relationship Management: Industry experts provide lessons learned and best practices for optimizing the bio/pharma company–supplier relationship.
- Special Reports: Special coverage of DCAT webinars and education programs, including programs from DCAT Week as well as other industry-focused reports.
DCAT Value Chain Insights 2022 Editorial Calendar: January-December 2022
January 7 |
Industry Radar: Bio/Pharma Industry Outlook A market outlook on bio/pharmaceutical industry performance for 2022 and beyond. |
January 14 |
The CDMO/CMO and Suppliers Report: The Year Ahead in Pharma Outsourcing An outlook for bio/pharmaceutical outsourcing for 2022. |
January 21 |
Manufacturing and Supply Lines: The Impact Factors for 2022 Industry experts provide perspective on what they see as the key issues impacting bio/pharma manufacturing and supply in 2022. |
January 28 |
Supplier Relationship Management: What’s Next for 2022? Bio/pharma companies and CDMOs/CMOs weigh in on what they see as the most significant issues shaping supplier relationships in 2022. |
February 4 |
Industry Radar: Small Molecules and Biologics Trend analysis of new molecular entities approvals and breakdown of small molecules and biologics. |
February 11 |
The CDMO/CMO and Suppliers Report: Parenteral Drugs Update of key expansions from CDMOs/CMOs in parenteral drug development and manufacturing. |
February 18 |
Manufacturing and Supply Lines: Fine Chemicals The outlook for fine chemicals supply and demand. |
February 25 |
Special Report: DCAT Week 2022 Preview Special preview of upcoming speakers and education programs at DCAT Week 2022 (March 21 to March 24, 2022). |
March 4 |
Special Report: DCAT Week 2022 Preview Special preview of upcoming speakers and education programs at DCAT Week 2022 (March 21 to March 24, 2022). |
March 11 |
The CDMO/CMO and Suppliers Report: Biomanufacturing Updates on key biomanufacturing expansions by CDMOs/CMOs. |
March 18 |
No issue DCAT Week 2022 (March 21 to March 24, 2022). |
March 25 |
No issue DCAT Week 2022 (March 21 to March 24, 2022). |
April 1 |
Special Report: DCAT Week 2022 in Review Detailed roundup from the DCAT Member Company Announcement Forum and the DCAT Research & Benchmarking Study as presented at DCAT Week 2022. |
April 8 |
Special Report: DCAT Week 2022 in Review Roundup from the education programs at DCAT Week 2022, including a bio/pharmaceutical industry outlook and executive insights. |
April 15 |
Manufacturing and Supply Lines: Clinical Trial Material Supply Industry experts weigh in on the key issues impacting clinical trial material supply, including the future of direct-to-patient supply. |
April 22 |
Supplier Relationship Management: Digitalization Examining how digital tools, such as AI, are and potentially can be applied in supply management of APIs and drug products. |
April 29 |
Special Report: The Global Bio/Pharma Pulse Leading developments from the US, EU, China, India, and Central and South America. |
May 6 |
Industry Radar: Generics and Biosimilars Near-term market outlook for generic drugs and biosimilars and update of key drugs coming off patent. |
May 13 |
The CDMO/CMO and Suppliers Report: Raw Materials Industry experts share perspectives on the issues impacting raw material supply, including energy and transportation inputs. |
May 20 |
Manufacturing and Supply Lines: Manufacturing 4.0 Analysis of key advances in automation and digitalization for bio/pharmaceutical manufacturing and the related market impact. |
May 27 |
Supplier Relationship Management: Orphan Drugs Industry experts provide insight on how to optimize project management for orphan drugs and other low-volume drugs. |
June 3 |
Industry Radar: Blockbuster Muscle Analysis and market projections for new drugs, launched or slated for market entry in 2022, with blockbuster potential. |
June 10 |
The CDMO/CMO and Suppliers Report: What’s Trending in Pharma Outsourcing The key trends and developments in the CDMO/CMO sector. |
June 17 |
Manufacturing and Supply Lines: Small-Molecule APIs Market overview for small-molecule active pharmaceutical ingredients (APIs) and supply–demand fundamentals. |
June 24 |
Supplier Relationship Management: Supplier-Led Innovation Case analysis of supplier-led innovation and how bio/pharma companies and CDMO/CMOs/suppliers brought to fruition. |
July 1 |
No issue |
July 8 |
The CDMO/CMO and Suppliers Report: High-Potency APIs Update on expansions by CDMOs/CMOs for high-potency active pharmaceutical ingredient (HPAPI) manufacturing and related trends. |
July 15 |
Manufacturing and Supply Lines: Inside Big Pharma’s Manufacturing Networks The latest manufacturing expansion activity among the bio/pharmaceutical majors. |
July 22 |
Supplier Relationship Management: Talent of the Future Examining evolving skillsets for sourcing professionals for effective supplier relationship management. |
July 29 |
Special Report: Trends in New Drug Approvals Examining the approvals of new molecular entities thus far in 2022, including trends in approvals for small molecules and biologics. |
August 5 |
Industry Radar: Emerging Pharma The start-ups and emerging bio/pharma companies gaining interest from investors and larger pharma companies in partnering deals. |
August 12 |
The CDMO/CMO and Suppliers Report: Formulation Development and Drug Products Latest market and technological advances for solid-dosage and parenteral drugs. |
August 19 |
Manufacturing and Supply Lines: Packaging Industry overview of key trends and developments in primary and secondary packaging. |
August 26 |
No issue |
September 2 |
Industry Radar: The Innovation Makers The companies, products, and executives leading in bio/pharma product innovation. |
September 9 |
The CDMO/CMO and Suppliers Report: Biomanufacturing Expansions and technology updates in upstream and downstream bioprocessing. |
September 16 |
Manufacturing and Supply Lines: Inside Europe In-depth analysis of key issues impacting the supply of raw materials, intermediates, and APIs in Europe. |
September 23 |
Supplier Relationship Management: Strategic Sourcing Bio/pharmaceutical companies and CDMOs/CMOs offer input on criteria and expectations for becoming a Tier 1 supplier. |
September 30 |
Special Report: Generic Drugs Latest market and regulatory update for generic drugs, including first generic drug approvals in 2022. |
October 7 |
Industry Radar: First-in-Class: Rising Pipeline Contenders Late-stage drug candidates with strong market potential. |
October 14 |
The CDMO/CMO and Suppliers Report: High-Potency Drug Products Update on expansions by CDMOs/CMOs for high-potency drug products and related trends. |
October 21 |
Manufacturing and Supply Lines: API Sourcing Industry roundtable on key trends/issues impacting sourcing for small-molecule active pharmaceutical ingredients (APIs) and intermediates. |
October 28 |
Supplier Relationship Management: Beyond Traditional Supplier Metrics Industry experts share insights on new metrics for evaluating supplier performance. |
November 4 |
Industry Radar: Cell and Gene Therapies Market outlook and manufacturing expansions for cell and gene therapies. |
November 11 |
The CDMO/CMO and Suppliers Report: Injectable Drugs Industry experts provide insight on key trends and technological developments for injectable drugs, including drug-device technology. |
November 18 |
Manufacturing and Supply Lines: Fine Chemicals Market outlook and key trends in the chemical manufacturing value chain for intermediates and active pharmaceutical ingredients. |
November 25 |
No issue Thanksgiving Holiday. |
December 2 |
Industry Radar: The Bio/Pharma Year in Review A look at the top developments in the bio/pharma industry in 2022. |
December 9 |
The CDMO/CMO and Suppliers Report: The Movers and Shakers of 2022 A look at the top expansions and mergers/acquisitions from CDMOs/CMOs in 2022. |
December 16 |
Manufacturing and Supply Lines: Small-Molecule APIs A look ahead of the key developments from 2022 shaping small-molecule API sourcing in 2023. |
There are no issues December 23 and December 30.